2018/03/08Our Company has been listed on the Forbes USA
2017/12/25¥3,700 million in additional funding raised through private placement of new shares.
2017/06/28To be featured at 2017 Japan US Innovation Awards Symposium at Stanford.
2016/05/01Kyoto Office and Kyoto Lab Expansion.
2016/04/12Our project adopted as a program of AMED(Japan Agency for Medical Research and Development) for Focused on Developing Key Evaluation Technology: Evaluation for Industrialization in the Field of Regenerative Medicine.
2015/11/25Commenced Collaborative Research with Harvard University (Boston Children's Hospital)
2015/08/20Articles about our project
2015/03/20Capital increased through private placement of new shares(Amount raised: ¥2,540 million)
2015/03/19Company officially recognized as a Designated Core Business within the Kansai National Strategic Special Zone